Real-time enrollment status for this endometrial adenocarcinoma clinical trial
Current Status
Recruiting
Checked: November 6, 2026 at 10:32 AM UTC
| NCT Number | NCT07867002 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Adenocarcinoma |
| Phase | PHASE3 |
| Target Enrollment | 140 participants |
| Active Locations | 6 sites in the US |
| Sponsor | UNC Lineberger Comprehensive Cancer Center |
| Last Updated on CT.gov | November 5, 2026 (Yesterday) |
As of November 6, 2026: Clinical trial NCT07867002 is currently recruiting participants. This phase3 study for endometrial adenocarcinoma is actively seeking new participants at 6 locations across the United States. The study is sponsored by UNC Lineberger Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07867002 is actively recruiting participants as of November 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07867002 was last updated Yesterday (November 5, 2026). HelloStudys verifies this status automatically.